- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-56-0010542

Avertis Remedies Private Limited
About Avertis Remedies Private Limited
Data last updated:
Avertis Remedies Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2014PTC067225. Its GSTIN is 09AANCA7981J1ZW (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.17 Lakh. It is led by directors including Shakeel Ahmed and Yaser Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.15 Haldauni, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.89 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹72,273 (net margin 0.4%) and EBITDA of ₹6.4 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 7% over five years.
As per MCA filings, the company has open charges of ₹55.5 Lakh on record.
Avertis Remedies Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-56-0010542). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Avertis Remedies
Contact details
Avertis Remedies Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.15 Haldauni, Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Avertis Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avertis Remedies is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Avertis Remedies Private Limited, buy the company report.
Financials of Avertis Remedies Private Limited
FY 2025 filings availableAvertis Remedies Private Limited reported revenue of ₹1.89 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 9% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹72,273 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avertis Remedies Private Limited, buy the company report.
Board of directors of Avertis Remedies Private Limited
Avertis Remedies has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shakeel Ahmed | Director | 25 Nov 2014 | 11 Years 11 Months | Current |
| Yaser Khan | Director | 25 Nov 2014 | 11 Years 11 Months | Current |
| Sakeela | Director | 25 Nov 2014 | 11 Years 11 Months | Current |
Auditor
Avertis Remedies Private Limited is audited by KRISHAN KUMAR AGARWAL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KRISHAN KUMAR AGARWAL & CO. | FY 2023 | 002020C |
Shareholding
The shareholding of Avertis Remedies Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Avertis Remedies Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Nov 2019 | 100299426 | Canara Bank | ₹55.5 Lakh | Open |
To see the full charge records of Avertis Remedies Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Avertis Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avertis Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Avertis Remedies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AANCA7981J1ZW | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Avertis Remedies Private Limited, buy the company report.
Recent activity
Avertis Remedies Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Sakeela was appointed as Director on 25 Nov 2014.
Frequently asked questions
Avertis Remedies is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 November 2014 (12+ years old) and is registered under CIN U24233UP2014PTC067225.
Avertis Remedies has 3 current directors:
- Shakeel Ahmed - Director
- Yaser Khan - Director
- Sakeela - Director
The latest financial statements of Avertis Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Avertis Remedies is 09AANCA7981J1ZW, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Avertis Remedies is U24233UP2014PTC067225. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avertis Remedies was incorporated on 25 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kanpur.
Sakeela was appointed as Director on 25 Nov 2014. Shakeel Ahmed was appointed as Director on 25 Nov 2014. Yaser Khan was appointed as Director on 25 Nov 2014.
Yes, Avertis Remedies is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-56-0010542).
The registered office of Avertis Remedies is at Plot No.15 Haldauni, Noida, Uttar Pradesh, India – 201301.
Avertis Remedies operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

